Overview
Guardant Health develops liquid biopsy tests for cancer detection and monitoring, with its Guardant360 CDx test FDA-approved for comprehensive genomic profiling of solid tumors from a simple blood draw.
More in Oncology Genomics
Tempus AI
Chicago, IL, USA
Adaptive Biotechnologies Corp.
Seattle, Washington, United States
Atrys
Madrid, Community of Madrid, Spain
Breast Cancer Foundation NZ
Auckland, Auckland, New Zealand
Breast Cancer Now
London, England, United Kingdom
Cancer Center of South Florida
West Palm Beach, Florida, United States
Company details
Category
🔬 Oncology Genomics
Location
Redwood City, CA
Funding
Public (GH)
Website
www.guardanthealth.comListed
2026-06-23
Is this your company?
Claim this listing to add your logo, full description, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach genomics professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →